Methotrexate and Basal cell carcinoma - from FDA reports


Summary

Basal cell carcinoma is found among people who take Methotrexate, especially for people who are female, 60+ old , have been taking the drug for 2 - 5 years, also take medication Folic Acid, and have Rheumatoid arthritis . We study 209,150 people who have side effects while taking Methotrexate from FDA. Among them, 1,072 have Basal cell carcinoma. Find out below who they are, when they have Basal cell carcinoma and more.

What to expect?

If you take Methotrexate and have Basal cell carcinoma, find out what symptoms you could have in 1 year or longer.

You are not alone!

Join a support group for people who take Methotrexate and have Basal cell carcinoma

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA since 1977. Our tools are simple to use, anonymous and free. Start now >>>

Methotrexate

Methotrexate has active ingredients of methotrexate sodium. It is often used in rheumatoid arthritis. (latest outcomes from Methotrexate 212,560 users)

Basal Cell Carcinoma

Basal cell carcinoma (a skin cancer, it rarely metastasizes or kills) has been reported by people with rheumatoid arthritis, osteoporosis, multiple sclerosis, high blood pressure, multiple myeloma (latest reports from 9,271 Basal cell carcinoma patients).

On Jan, 28, 2017

209,150 people reported to have side effects when taking Methotrexate.
Among them, 1,072 people (0.51%) have Basal Cell Carcinoma


Number of reports submitted per year:

Could Methotrexate cause Basal cell carcinoma?

Time on Methotrexate when people have Basal Cell Carcinoma *:

  • < 1 month: 10.98 %
  • 1 - 6 months: 8.54 %
  • 6 - 12 months: 14.63 %
  • 1 - 2 years: 15.85 %
  • 2 - 5 years: 23.17 %
  • 5 - 10 years: 18.29 %
  • 10+ years: 8.54 %

Gender of people who have Basal Cell Carcinoma when taking Methotrexate *:

  • female: 66.7 %
  • male: 33.3 %

Age of people who have Basal Cell Carcinoma when taking Methotrexate *:

  • 0-1: 0.0 %
  • 2-9: 0.52 %
  • 10-19: 0.52 %
  • 20-29: 1.04 %
  • 30-39: 1.17 %
  • 40-49: 10.55 %
  • 50-59: 18.75 %
  • 60+: 67.32 %

Top conditions involved for these people *:

  • Rheumatoid Arthritis (626 people, 58.40%)
  • Osteoporosis (66 people, 6.16%)
  • Psoriatic Arthropathy (62 people, 5.78%)
  • High Blood Pressure (49 people, 4.57%)
  • Crohn's Disease (47 people, 4.38%)

Top co-used drugs for these people *:

  • Folic Acid (380 people, 35.45%)
  • Remicade (350 people, 32.65%)
  • Humira (165 people, 15.39%)
  • Prednisone (159 people, 14.83%)
  • Enbrel (126 people, 11.75%)

Top other side effects for these people *:

  • Pain (82 people, 7.65%)
  • Squamous Cell Carcinoma (75 people, 7.00%)
  • Rashes (73 people, 6.81%)
  • Osteoarthritis (62 people, 5.78%)
  • Stress And Anxiety (61 people, 5.69%)

* Approximation only. Some reports may have incomplete information.

** Reports from social media are used.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you have Basal cell carcinoma when taking Methotrexate?

Browse all side effects of Methotrexate

a b c d e f g h i j k l m n o p q r s t u v w x y z

Drugs that are associated with Basal cell carcinoma

Basal cell carcinoma

Could your condition cause Basal cell carcinoma

Basal cell carcinoma

Related studies

Can you answer these questions?

More questions for: Methotrexate, Basal cell carcinoma

You may be interested in these reviews

More reviews for: Methotrexate, Basal cell carcinoma